The CliniMACS Prodigy device, tubing set TS520 and TCT software allow CAR-T cells to be manufactured in a closed system at the treatment site without need for clean-room facilities and related infrastructure.ĬliniMACS Prodigy chimeric antigen receptor T cells immunotherapy lentiviral vectors.Ĭopyright © 2017 International Society for Cellular Therapy. Bioz Stars score: 93/100, based on 1 PubMed citations. Functional testing demonstrated recognition of B-cells and for the CAR-20/19 T cells, CD19 and CD20 single transfectants were recognized in cytotoxic T lymphocyte and interferon-γ production assays. Macs Gmp Expact T Reg Kit, supplied by Miltenyi Biotec, used in various techniques. CAR-T cells were 82-100% CD3 + with a mix of CD4 + and CD8 + cells that primarily expressed an effector-memory or central-memory phenotype. Despite standard treatment with chemotherapeutic agents, including anthracycline and cytarabine, to achieve complete remission. An average 30-fold expansion of 10 8 CD4/CD8-enriched cells resulted in sufficient transduced T cells for clinical use. 0 Comments Only 3545 of patients under the age of 60 years experience long-term remission with conventional treatment, and the proportion drops to 1015 for those older than 60 years. Vectors at multiplicity of infection 5-10 resulted in transduction averaging 37%. Methods, Results & Conclusion Lentivirally-transduced CAR-T cells were cultured in flasks in Miltenyi TexMACS medium with or without human AB serum (HABS). Processing time was 13 days.Įnrichment (N = 7) resulted in CD4/CD8 purity of 98 ± 4.0%, 55 ± 6% recovery and CD3 + T-cell purity of 89 ± 10%. Global Cell Separation Technology Market Report 2023: Featuring Terumo, Merck, Miltenyi Biotec, Bio-Rad Laboratories & More News provided by. We used MACS-CD4 and CD8-MicroBeads for enrichment, TransAct CD3/CD28 reagent for activation, lentiviral CD8 TM-41BB-CD3 ζ-cfrag vectors expressing scFv for CD19 or CD20/CD19 antigens for transduction, TexMACS medium-3%-HS-IL2 for culture and phosphate-buffered saline/ethylenediaminetetraacetic acid buffer for washing. The CliniMACS Prodigy with TCT process software and the TS520 tubing set that allows closed-system processing for cell enrichment, transduction, washing and expansion was used. Supernatants were collected at the endpoint and used to detect the cytokines released by anti-CD20 CAR T cells using the MACSPlex Cytokine 12 Kit (Miltenyi Biotec) with the four selected human cytokines IFN-, IL-2, TNF- and GM-CSF, according to the manufacturer's instructions. Simplified, reproducible CAR-T-cell manufacturing with reduced labor intensity within a closed-system is highly desirable for increased availability for patients. This complex process requires skilled personnel and costly clean-room facilities and infrastructure. Open processing steps that increase risk of contamination and production failure are required. Multiple steps are required to produce chimeric antigen receptor (CAR)-T cells, involving subset enrichment or depletion, activation, gene transduction and expansion.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |